← Leaderboards
James S. Economou
University Of California Los Angeles
$9,911,213
Attributed
$9,911,213
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$9,911,213 · 8
By mechanism
R01$5,399,807 · 3
K12$3,175,788 · 1
T32$1,281,705 · 1
M01$53,913 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Hsian-Rong Tseng$15,333,457
- Antoni Ribas$28,929,216
- Michael A Teitell$22,516,970
- Vatche Agopian$3,720,225
- Yazhen Zhu$5,188,074
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyHuman SubjectLaboratory MouseClinical ResearchNeoplasm /Cancer ImmunotherapyDendritic CellsClinical TrialsNeoplasm /Cancer VaccineHuman Therapy EvaluationClinical Trial Phase IGenetically Modified AnimalsNeoplasm /Cancer ImmunologyMelanomaTransfection /Expression VectorPatient Oriented ResearchProgramsEnzyme Linked Immunosorbent AssayAlpha FetoproteinMedicineNeoplasm /Cancer EducationCd8b1 GeneCollaborationsImmune ResponseAntigens
Grant awards (40)
PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN$283,822
R01 · FY2011 · CA · contact PI
PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN$292,600
R01 · FY2010 · CA · contact PI
PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN$292,600
R01 · FY2009 · CA · contact PI
PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN$292,600
R01 · FY2008 · CA · contact PI
UCLA Clinical Scientist Training in Cancer Gene Medicine$508,680
K12 · FY2007 · CA · contact PI
PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN$279,344
R01 · FY2007 · CA · contact PI
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$124,483
R01 · FY2007 · CA · contact PI
UCLA Clinical Scientist Training in Cancer Gene Medicine$508,680
K12 · FY2006 · CA · contact PI
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$323,914
R01 · FY2006 · CA · contact PI
UCLA CANCER GENE MEDICINE TRAINING PROGRAM$217,859
T32 · FY2006 · CA · contact PI
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$146,775
R01 · FY2006 · CA · contact PI
A PHASE I TRIAL TESTING IMMUNIZATION WITH DENDRITIC CELLS PULSED WITH FOUR AF$10,410
M01 · FY2006 · RR · contact PI
UCLA Clinical Scientist Training in Cancer Gene Medicine$508,680
K12 · FY2005 · CA
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$349,326
R01 · FY2005 · CA
UCLA CANCER GENE MEDICINE TRAINING PROGRAM$209,069
T32 · FY2005 · CA
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$135,543
R01 · FY2005 · CA
A PHASE I TRIAL TESTING IMMUNIZATION WITH DENDRITIC CELLS PULSED WITH FOUR AF$15,880
M01 · FY2005 · RR
A PHASE I TRIAL TESTING MART-1 GENETIC IMMUNIZATION IN MALIGNANT MELANOMA$1,155
M01 · FY2005 · RR
UCLA Clinical Scientist Training in Cancer Gene Medicine$508,680
K12 · FY2004 · CA
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$346,478
R01 · FY2004 · CA
Genetic Immunotherapy for Hepatocellular Cancer$320,477
R01 · FY2004 · CA
UCLA CANCER GENE MEDICINE TRAINING PROGRAM$233,016
T32 · FY2004 · CA
Phase I Trial Testing Immunization with Dendritic Cell$19,919
M01 · FY2004 · RR
Phase I Trial Testing MART-1 Genetic Immunization in M$6,549
M01 · FY2004 · RR
UCLA Clinical Scientist Training in Cancer Gene Medicine$470,621
K12 · FY2003 · CA
Genetic Immunotherapy for Hepatocellular Cancer$308,729
R01 · FY2003 · CA
Dendritic Cell-Based Genetic Immunotherapy for Melanoma$298,269
R01 · FY2003 · CA
UCLA CANCER GENE MEDICINE TRAINING PROGRAM$204,685
T32 · FY2003 · CA
Genetic Immunotherapy for Hepatocellular Cancer$330,924
R01 · FY2002 · CA
DENDRITIC CELL BASED GENETIC IMMUNOTHERAPY FOR MELANOMA$252,633
R01 · FY2002 · CA
CLINICAL SCIENTIST TRAINING IN CANCER GENE MEDICINE$225,461
K12 · FY2002 · CA
UCLA CANCER GENE MEDICINE TRAINING PROGRAM$166,007
T32 · FY2002 · CA
Genetic Immunotherapy for Hepatocellular Cancer$304,336
R01 · FY2001 · CA
DENDRITIC CELL BASED GENETIC IMMUNOTHERAPY FOR MELANOMA$272,671
R01 · FY2001 · CA
CLINICAL SCIENTIST TRAINING IN CANCER GENE MEDICINE$225,462
K12 · FY2001 · CA
UCLA GENE MEDICINE TRAINING PROGRAM$106,344
T32 · FY2001 · CA
DENDRITIC CELL BASED GENETIC IMMUNOTHERAPY FOR MELANOMA$261,909
R01 · FY2000 · CA
CLINICAL SCIENTIST TRAINING IN CANCER GENE MEDICINE$219,524
K12 · FY2000 · CA
GENETIC IMMUNIZATION OF HEPATOCELLULAR CANCER$182,374
R01 · FY2000 · CA
UCLA GENE MEDICINE TRAINING PROGRAM$144,725
T32 · FY2000 · CA